Dextroamphetamine as an Adjunct in Cocaine Treatment - 1
Information source: National Institute on Drug Abuse (NIDA)
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Cocaine-Related Disorders; Substance-Related Disorders
Intervention: Dextroamphetamine (Drug)
Phase: Phase 2
Status: Completed
Sponsored by: National Institute on Drug Abuse (NIDA) Official(s) and/or principal investigator(s):
John Grabowski, Ph.D., Principal Investigator, Affiliation: University of Texas
Summary
The purpose of this study is to evaluate dextroamphetamine sulfate (sustained release) as an
adjunct in cocaine treatment; an evaluation of the ""replacement"" strategy.
Clinical Details
Official title: Dextroamphetamine as an Adjunct in Cocaine Treatment
Study design: Treatment
Primary outcome: CravingDrug use Medication compliance Retention Addiction severity Mood indicators Psychiatric interview
Eligibility
Minimum age: 18 Years.
Maximum age: 45 Years.
Gender(s): Both.
Criteria:
Please contact site for information.
Locations and Contacts
University of Texas Health Science Center, Houston, Texas 77225, United States
Additional Information
Last updated: August 16, 2005
|
